Norethisterone acetate oxime: Difference between revisions
Content deleted Content added
Zakblade2000 (talk | contribs) No edit summary |
m added FDA UNII to drug box |
||
| Line 31: | Line 31: | ||
| CAS_number = 20799-24-0 |
| CAS_number = 20799-24-0 |
||
| CAS_supplemental = |
| CAS_supplemental = |
||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
| UNII = VFK4D40PMQ |
|||
| ATC_prefix = |
| ATC_prefix = |
||
| ATC_suffix = |
| ATC_suffix = |
||
Revision as of 15:26, 1 April 2020
 | |
| Clinical data | |
|---|---|
| Other names | Norethindrone acetate oxime; ORF-5263; So-36; Norethisterone-3-oxime acetate; 17α-Ethynyl-19-nortestosterone 3-oxime 17β-acetate |
| Routes of administration | By mouth |
| Drug class | Progestogen; Progestogen ester |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| Chemical and physical data | |
| Formula | C22H29NO3 |
| Molar mass | 355.471 g/mol g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Norethisterone acetate oxime (developmental code names ORF-5263, So-36), or norethindrone acetate oxime, is a steroidal progestin of the 19-nortestosterone group which was developed as a postcoital contraceptive but was never marketed.[1] It is the C3 oxime and C17β-acetate ester of norethisterone.[1]
See also
References
- ^ a b J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 886–. ISBN 978-1-4757-2085-3.
 | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |
 | This article about a steroid is a stub. You can help Wikipedia by expanding it. |